Investigation of Tipifarnib in Treatment of Subjects With Peripheral T-Cell Lymphoma (PTCL) That Have Not Responded to Standard Therapy

Institut Catala d'Oncologia de Girona, Girona

MD Anderson Cancer Center Madrid, Madrid

Hospital Universitario 12 Octubre de Madrid, Madrid

H. Lee Moffitt Cancer Center & Research Institute, Inc., Tampa

Hospital Universitario de Salamanca, Salamanca

Hospital Universitario Virgen del Rocio, Seville

Hospital Clinico Universitario de Valencia, Valencia

Mayo Clinic, Rochester

Stanford University Medical Center, Palo Alto

Yale University, Yale Cancer Center, New Haven

Dana-Farber Cancer Institute, Boston

Samsung Medical Center, Seoul

Hospital Universitari Vall d'Hebron, Barcelona